News
High Tide Subsidiary Blessed CBD Included in UK Food Standards Agency’s Public List of Cannabinoid Products Permitted for Sale
Inclusion on the list represents a key stage on the path to full authorization, expected by 2023
CALGARY, March 31, 2022 - High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI)
Kodiak Closes Oversubscribed Upsized Bought Deal Financing and Non-Brokered Private Placement for Gross Proceeds of C$9.6 Million
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
March 31, 2022 – Vancouver, British Columbia – Kodiak Copper Corp. (the
WELL Health Achieves Record Results Reflecting 573% YoY Revenue Growth and Positive Net Income in Q4-2021
- WELL reported record quarterly revenues of $115.7 million in Q4-2021 representing a 573% year-over-year (YoY) increase compared to Q4-2020. WELL’s annual revenue for 2021 was $30
Discovery Intercepts 328 g/t AgEq over 46 m Outside Current Resource at Cordero
March 31, 2022, Toronto, Ontario - Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/discovery-metals-co
Metallis Confirms Lead Appointment to Exploration Team
March 31, 2022, Vancouver, BC: Metallis Resources Inc. (TSX-V: MTS; OTCQB: MTLFF; FSE: 0CVM) (the “Company” or “Metallis”) is
Bee Vectoring Technologies Announces Ongoing 2022 Almond Trials in California; Disease and Yield Data to Come
Mississauga, ON Canada and Sacramento, CA USA (March 31, 2022) – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE) today announced it
Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food Products
Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food
Victory Completes Smokey Lithium Drilling Program Phase One
- Phase One, 3 of 15-hole Drill Program, is focused on determining the relationship to High Li Zone on the adjacent Jindalee Property
- Exploration team is optimistic, as
XORTX Files IND with US FDA
- Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program IND Filed -
CALGARY, AB – March 31, 2022 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX I TSXV: XRTX I
Asante Gold Announces Appointment of Executive Vice President & Country Director
Vancouver, British Columbia, March 31, 2022 – Asante Gold Corporation (CSE:ASE | FRANKFURT:1A9 | U.S.OTC:ASGOF) (“Asante” or the “Company”) is pleased to announce the appointment of Frederick
Aurania Announces Closing of Private Placement
THIS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Toronto, Ontario,
Datametrex Successfully Completes First Phase of $40M AI Contract
Toronto, Canada, March 31, 2022 – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company and its wholly owned
MARVEL SUBSIDIARY NEW MARVEL ENERGY TO FOCUS ON SMR ENERGY APPLICATIONS FOR LAND AND FUEL
March 31, 2022. Vancouver, B.C. – Marvel Discovery Corp. (TSX-V: MARV), (Frankfurt: O4T1), (MARVF: OTCQB); (the “Company”) is
TUGA Launches Brand Positioning Campaign
- Proactive Brand Identity Program Targets Premium Product Recognition
VANCOUVER, BC and LISBON, PORTUGAL — (March 31, 2022) – TUGA Innovations, Inc. (CSE: TUGA) (FRA: DQ5)
Majestic Announces Listing Application to HKEX for IPO of Subsidiary Sinogold Resources Holdings Group Co., Ltd.
Vancouver, British Columbia - March 30, 2022. Majestic Gold Corp. ("Majestic" or the "Company") (TSX-V: MJS) is pleased to announce that its 94% owned subsidiary, SINOGOLD Resources
Vicinity Motor Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
Fourth Quarter Illustrates Inherently Fluctuating Nature of Transit Bus Revenue Amongst a Record Full Year
VANCOUVER, BC – March 30, 2022 – Vicinity Motor Corp. (NASDAQ:VEV) (TSXV:VMC)
MetalsTech: Significant Exploration Target Defined at the Sturec Gold Project
30 March 2022
Highlights
- Significant JORC (2012) Exploration Target defined at the Company’s 100% owned Sturec Gold Mine, central Slovakia, of between 37.9Mt and 58.2Mt at an
Universal Mobilizes Diamond Drill to Poplar
Vancouver, British Columbia, March 30, 2022 – Universal Copper Ltd. ("Universal Copper" or the "Company") (TSX Venture: UNV) (Frankfurt: 3TA2) is pleased to announce drill mobilization for
High Tide to Acquire Bud Heaven, Adding Two Established Retail Cannabis Stores in Ontario
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 3, 2021 to its short form base shelf prospectus dated April
IperionX Files Registration Statement for Proposed U.S. Listing
30 March 2022 – IperionX Limited (“IperionX” or “Company”) (ASX: IPX) is pleased to announce positive progress on its proposed U.S. listing on the Nasdaq Capital Market (“Nasdaq”).
Iperio
The Yumy Candy Company Announces that Yumy Bears Have Landed at Another Industry Leading Grocery Store Chain IGA
VANCOUVER, BC, March 30, 2022, The Yumy Candy Company Inc., (CSE: TYUM) ("Yumy" or the "Company") The Yumy Candy Company Inc. will roll out its low-sugar better-for-you confectionery products
Juva Life Launches First In-House Branded Product: ‘Secret Sauce’ Concentrate – in Response to Market Segment Growth
Vertically Integrated California Cultivator and Life Science Research Company Expands Strategically Into New Category
VANCOUVER, British Columbia, March 30, 2022 – Juva Life Inc. (CSE:
BioVaxys Expands Cancer Vaccine Platform
- BVX-0922 to Target Colorectal Cancer Under Investigator-Sponsored IND
Vancouver, British Columbia, March 30th, 2022 - BioVaxys Technology Corp. (CSE:BIOV, FRA:5LB, OTCQB:BVAXF)
Positive Safety Data from Fourth Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
- 10 subjects in Cohort Four intravenously dosed; RECCE® 327 at 1,000mg indicating to be safe and well tolerated
- Independent Safety Committee to review